Page last updated: 2024-11-04

sumatriptan and Hyperesthesia

sumatriptan has been researched along with Hyperesthesia in 1 studies

Sumatriptan: A serotonin agonist that acts selectively at 5HT1 receptors. It is used in the treatment of MIGRAINE DISORDERS.
sumatriptan : A sulfonamide that consists of N,N-dimethyltryptamine bearing an additional (N-methylsulfamoyl)methyl substituent at position 5. Selective agonist for a vascular 5-HT1 receptor subtype (probably a member of the 5-HT1D family). Used (in the form of its succinate salt) for the acute treatment of migraine with or without aura in adults.

Hyperesthesia: Increased sensitivity to cutaneous stimulation due to a diminished threshold or an increased response to stimuli.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Diamond, S1
Freitag, FG1
Feoktistov, A1
Nissan, G1

Trials

1 trial available for sumatriptan and Hyperesthesia

ArticleYear
Sumatriptan 6 mg subcutaneous as an effective migraine treatment in patients with cutaneous allodynia who historically fail to respond to oral triptans.
    The journal of headache and pain, 2007, Volume: 8, Issue:1

    Topics: Administration, Oral; Adult; Drug Tolerance; Female; Humans; Hyperesthesia; Injections, Subcutaneous

2007